article thumbnail

Digital Therapeutics Might Address Gaps in Care for Mental Health Patients

Pharmacy Times

Pharmacists should be well educated on prescription digital therapeutics to better educate patients on software in comparison to traditional pharmacological products.

article thumbnail

Chiesi joins with Aptar on digital platform for respiratory patients

pharmaphorum

It will combine the pharmacological and behavioural aspects of managing respiratory diseases, according to the partners, such as “adherence monitoring, lung function assessment, reporting symptoms, identifying disease triggers and communication with care teams and health coaches.” billion of its total revenues of €2.4

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cala® Launches The Cala kIQ™ System, Offering Meaningful Tremor Relief for Patients With Essential Tremor and Now Parkinson’s Disease

Legacy MEDSearch

The Cala kIQ System with TAPS therapy offers a non-invasive, non-pharmacologic solution with minimal side effects. Treatment options for these conditions have historically been medications or, in more severe cases – surgery.

article thumbnail

How NLP Helps Life Sciences Companies Unlock Insights from Drug Labels

PM360

Typically, a drug label refers to any information provided with prescription drugs, as requested by regulators such as the U.S. Food and Drug Administration (FDA) or European Medicines Agency (EMA).

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs. Learning Objectives: Dose-response curves and patient treatment: How do pharmacologic and toxicologic principles apply to the dosing of drugs in clinical development?

article thumbnail

Pharma Injecting Life into Digital Health Amidst Funding Downturn

MedCity News

The earliest higher-profile digital therapeutic leaders focused on mental and behavioral health with some earning Food and Drug Administration approval for managing conditions such as attention-deficit and hyperactivity disorder, substance-use disorder, and insomnia using a prescription-level app alone or in conjunction with pharmacologic therapy.

Pharma 106
article thumbnail

Psychedelic medicines: are they gaining traction in Europe?

European Pharmaceutical Review

Australia recently re-classified MDMA and psilocybin to allow prescription of MDMA for the treatment of post-traumatic stress disorder and psilocybin for treatment-resistant depression by psychiatrists. Pharmacological Reviews. Additionally, several US and Canadian states have legalised or decriminalised magic mushrooms. Psychedelics.

Medicine 110